Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640James W. Antoon, Barbara S. Beckman|Endocrinology|2010Cited by 114
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancerJames W. Antoon, Barbara S. Beckman|Journal of Molecular Endocrinology|2011Cited by 49
Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired ChemoresistanceJames W. Antoon, Matthew E. Burow|Scientific Reports|2012Cited by 37